FDCC
MDT icon

Foster Dykema Cabot & Co’s Medtronic MDT Stock Holding History

Foster Dykema Cabot & Co’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$131K Hold
1,669
– – 0.02% 119
2023
Q2 		$147K Hold
1,669
– – 0.02% 114
2023
Q1 		$135K Buy
+1,669
New +$136K 0.02% 105

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Foster Dykema Cabot & Co's MDT Position: Q3 2023 in Review

Foster Dykema Cabot & Co held its Medtronic (MDT) position steady in Q3 2023 at 1,669 shares worth $131K. The position accounts for 0.02% of the portfolio, ranked #119.

Foster Dykema Cabot & Co first reported a position in MDT in Q1 2023 and has held it in 3 quarters since. The position peaked at $147K in Q2 2023. 1,970 funds tracked by Wall St. Rank hold MDT as of Q3 2023.

  • Foster Dykema Cabot & Co held 1,669 shares of Medtronic worth $131K as of Q3 2023.
  • Foster Dykema Cabot & Co left its Medtronic share count unchanged in Q3 2023.
  • Medtronic made up 0.02% of Foster Dykema Cabot & Co's portfolio in Q3 2023, its #119 holding.
  • Foster Dykema Cabot & Co first reported a position in Medtronic in Q1 2023 and has held it in 3 quarters since.
  • Foster Dykema Cabot & Co's Medtronic position peaked at $147K in Q2 2023.
  • 1,970 funds tracked by Wall St. Rank held Medtronic as of Q3 2023.

Based on Foster Dykema Cabot & Co's 13F filing for Q3 2023, filed 14 Nov 2023.